These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24106408)

  • 21. [Effects of salvianolic acid B and diammonium glycyrrhizinate on portal pressure in rats].
    Zhou H; Wang SX; Zhang T
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Oct; 30(10):1084-6. PubMed ID: 21066895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model.
    Sakamoto M; Nakamura T; Torimura T; Iwamoto H; Masuda H; Koga H; Abe M; Hashimoto O; Ueno T; Sata M
    J Gastroenterol Hepatol; 2013 Jan; 28(1):168-78. PubMed ID: 22849788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis.
    Fortea JI; Zipprich A; Fernandez-Mena C; Puerto M; Bosoi CR; Almagro J; Hollenbach M; Bañares J; Rodríguez-Sánchez B; Cercenado E; Clément MA; Rose CF; Bañares R; Vaquero J; Ripoll C
    Liver Int; 2018 Jan; 38(1):102-112. PubMed ID: 28665498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease.
    Boyer-Diaz Z; Aristu-Zabalza P; Andrés-Rozas M; Robert C; Ortega-Ribera M; Fernández-Iglesias A; Broqua P; Junien JL; Wettstein G; Bosch J; Gracia-Sancho J
    J Hepatol; 2021 May; 74(5):1188-1199. PubMed ID: 33278455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuation of portal hypertension by natural taurine in rats with liver cirrhosis.
    Liang J; Deng X; Lin ZX; Zhao LC; Zhang XL
    World J Gastroenterol; 2009 Sep; 15(36):4529-37. PubMed ID: 19777611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of portal hypertension and hepatic blood flow in cirrhotic rats by oestrogen.
    Sakamoto M; Ueno T; Nakamura T; Sakata R; Hasimoto O; Torimura T; Sata M
    Eur J Clin Invest; 2005 Mar; 35(3):220-5. PubMed ID: 15733078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension.
    Wang JJ; Gao GW; Gao RZ; Liu CA; Ding X; Yao ZX
    World J Gastroenterol; 2004 Mar; 10(5):689-93. PubMed ID: 14991939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of inducible nitric oxide synthase in gastric mucosa of rats with portal hypertension: correlation with gastric mucosal damage.
    Hsieh JS; Wang JY; Lin SR; Lian ST; Chen FM; Hsieh MC; Huang TJ
    J Surg Res; 2003 Nov; 115(1):24-32. PubMed ID: 14572769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of inducible nitric oxide synthase leads to increased hepatic apoptosis and decreased fibrosis in mice after chronic carbon tetrachloride administration.
    Aram G; Potter JJ; Liu X; Torbenson MS; Mezey E
    Hepatology; 2008 Jun; 47(6):2051-8. PubMed ID: 18506890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The anti-portal hypertension effect of oleanolic acid in CCl4-induced cirrhosis rats].
    Liu CH; Huang XT; Li YY; Zheng X; Li N; Mi SQ; Wang NS
    Zhong Yao Cai; 2012 Jun; 35(6):930-5. PubMed ID: 23236829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphological and biomechanical remodeling of the hepatic portal vein in a swine model of portal hypertension.
    He XJ; Huang TZ; Wang PJ; Peng XC; Li WC; Wang J; Tang J; Feng N; Yu MH
    Ann Vasc Surg; 2012 Feb; 26(2):259-67. PubMed ID: 22192237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intestinal endotoxemia plays a central role in development of hepatopulmonary syndrome in a cirrhotic rat model induced by multiple pathogenic factors.
    Zhang HY; Han DW; Su AR; Zhang LT; Zhao ZF; Ji JQ; Li BH; Ji C
    World J Gastroenterol; 2007 Dec; 13(47):6385-95. PubMed ID: 18081228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A selective cyclo-oxygenase-2 inhibitor, NS-398, may improve portal hypertension without inducing gastric mucosal injury.
    Tsugawa K; Hashizume M; Migou S; Kishihara F; Kawanaka H; Tomikawa M; Sugimachi K
    J Gastroenterol Hepatol; 1999 Jul; 14(7):642-51. PubMed ID: 10440208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.
    Reboredo M; Chang HC; Barbero R; Rodríguez-Ortigosa CM; Pérez-Vizcaíno F; Morán A; García M; Banales JM; Carreño N; Alegre F; Herrero I; Quiroga J; Prieto J; Sangro B
    PLoS One; 2013; 8(1):e52683. PubMed ID: 23341903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension.
    Rockey DC; Chung JJ
    Gastroenterology; 1998 Feb; 114(2):344-51. PubMed ID: 9453496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis.
    Klein S; Rick J; Lehmann J; Schierwagen R; Schierwagen IG; Verbeke L; Hittatiya K; Uschner FE; Manekeller S; Strassburg CP; Wagner KU; Sayeski PP; Wolf D; Laleman W; Sauerbruch T; Trebicka J
    Gut; 2017 Jan; 66(1):145-155. PubMed ID: 26385087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asymmetric dimethylarginine (ADMA) determines the improvement of hepatic endothelial dysfunction by vitamin E in cirrhotic rats.
    Yang YY; Lee TY; Huang YT; Chan CC; Yeh YC; Lee FY; Lee SD; Lin HC
    Liver Int; 2012 Jan; 32(1):48-57. PubMed ID: 22098317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites.
    López-Talavera JC; Levitzki A; Martínez M; Gazit A; Esteban R; Guardia J
    J Clin Invest; 1997 Aug; 100(3):664-70. PubMed ID: 9239414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bile Acids and Portal Hypertension.
    Arab JP; Barrera F; Arrese M
    Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s83-s86. PubMed ID: 29080345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo gene transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetised carbon tetrachloride cirrhotic rats.
    Van de Casteele M; Omasta A; Janssens S; Roskams T; Desmet V; Nevens F; Fevery J
    Gut; 2002 Sep; 51(3):440-5. PubMed ID: 12171971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.